Please login to the form below

Not currently logged in
Email:
Password:

Covington boosts European life sciences group

New partner and an associate will focus on issues involving EU law

Adem Koyuncu, CovingtonLegal firm Covington & Burling has added a new partner and an associate to strengthen its efforts in EU law for life sciences companies.

New partner Dr Adem Koyuncu (pictured) is qualified as both a lawyer and medical doctor, and will join Covington's compliance practice, heading the firm's German life sciences practice.

A leading life sciences lawyer, he has worked on EU and German regulatory issues concerned with pharmaceuticals, medical devices and other health and consumer products.

Koyuncu has also worked in compliance, privacy and product liability matters, along with assisting life sciences clients with corporate transactions. He joins Covington from another international law firm, where he was partner and co-chair of the global life sciences group.

Covington's Brussels office serves as a hub for EU clients, and the firm hopes that appointing Koyuncu will enhance its ability to advise a broad range of clients across German and the wider European Union.

"Dr Koyuncu's arrival significantly strengthens our ability to advise a broad range of clients in the pharmaceuticals and medical devices industries on matters in Germany, the EU and Europe,” said Covington chairman Timothy Hester.

Joining Covington alongside Koyuncu is new associate Sabine Stute, who is also licensed to practice law in Germany. Both will be based in Brussels.

7th January 2014

From: Sales, Regulatory

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics